Global Blood Culture Test Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030

List of Tables

The global demand for Blood Culture Test Market is presumed to reach the market size of nearly USD 11.13 BN by 2030 from USD 5.54 BN in 2022 with a CAGR of 9.1% under the study period 2023 - 2030.

A blood culture test is a medical diagnostic procedure which is used to detect the presence of bacteria, fungi, or other microorganisms (pathogens) in a patient's bloodstream. The test is crucial in diagnosing bloodstream infections or sepsis, a severe and potentially life-threatening condition.

MARKET DYNAMICS:

The growing incidence of sepsis and bloodstream infections worldwide is a significant driver, as timely and accurate diagnosis is crucial for effective treatment. Healthcare facilities' increasing focus on infection control measures also contributes to the demand for blood culture tests to identify infections early and implement appropriate measures. Technological advancements in blood culture technology, including automated systems and continuous monitoring, have improved the sensitivity and speed of pathogen detection, enhancing patient outcomes. Additionally, the rising number of patients with compromised immune systems and the importance of antimicrobial stewardship to combat antimicrobial resistance fuel the market's growth. Furthermore, increasing healthcare spending and infrastructure development in developing countries and the impact of the COVID-19 pandemic, which emphasizes the importance of early infection diagnosis, also contribute to the demand for blood culture tests.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of blood culture test. The growth and trends of blood culture test industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the blood culture test market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Method

Conventional/Manual Methods
Automated Methods

By Product

Consumables (Blood Culture Media, Assay Kits & Reagents, Blood Culture Accessories)
Instruments (Automated Blood Culture Systems, Supporting Laboratory Equipment)
Software And Services

By Technology

Culture-Based Technology
Molecular Technologies
Microarrays
Pcr (Polymerase Chain Reaction)
Pna-Fish (Peptide Nucleic Acid - Fluroscent In Situ Hybridization)
Proteomics Technology

By Application

Bacteremia
Fungemia
Mycobacterial Detection

By End User

Hospital Laboratories
Reference Laboratories
Academic Research Laboratories
Other Laboratories

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Blood Culture Test market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Blood Culture Test market include Becton, Dickinson and Company (US), bioMerieux SA (France), and Thermo Fisher Scientific Inc. (US), Luminex Corporation (US), Danaher Corporation (US), Bruker Corporation (US), IRIDICA (a subsidiary of Abbott Laboratories) (US), Roche Diagnostics (Switzerland), T2 Biosystems, Inc. (US), Anaerobe Systems, Inc. (US), OpGen, Inc. (US), Meditech Technologies India Private Limited (India), Carl Zeiss AG (Germany), Nikon Corporation (Japan), BINDER GmbH (Germany), Biobase Biotech (Jinan) Co. Ltd. (China). This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

Product Code: VMR112111745

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . BLOOD CULTURE TEST - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Method
- 3.7.2 Market Attractiveness Analysis By Product
- 3.7.3 Market Attractiveness Analysis By Technology
- 3.7.4 Market Attractiveness Analysis By Application
- 3.7.5 Market Attractiveness Analysis By End User
- 3.7.6 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . GLOBAL BLOOD CULTURE TEST MARKET ANALYSIS BY METHOD

5.1 Overview by Method
5.2 Historical and Forecast Data
5.3 Analysis by Method
5.4 Conventional/Manual Methods Historic and Forecast Sales by Regions
5.5 Automated Methods Historic and Forecast Sales by Regions

6 . GLOBAL BLOOD CULTURE TEST MARKET ANALYSIS BY PRODUCT

6.1 Overview by Product
6.2 Historical and Forecast Data
6.3 Analysis by Product
6.4 Consumables (Blood Culture Media, Assay Kits & Reagents, Blood Culture Accessories) Historic and Forecast Sales by Regions
6.5 Instruments (Automated Blood Culture Systems, Supporting Laboratory Equipment) Historic and Forecast Sales by Regions
6.6 Software And Services Historic and Forecast Sales by Regions

7 . GLOBAL BLOOD CULTURE TEST MARKET ANALYSIS BY TECHNOLOGY

7.1 Overview by Technology
7.2 Historical and Forecast Data
7.3 Analysis by Technology
7.4 Culture-Based Technology Historic and Forecast Sales by Regions
7.5 Molecular Technologies Historic and Forecast Sales by Regions
7.6 Microarrays Historic and Forecast Sales by Regions
7.7 PCR (Polymerase Chain Reaction) Historic and Forecast Sales by Regions
7.8 PNA-FISH (Peptide Nucleic Acid - Fluroscent in Situ Hybridization) Historic and Forecast Sales by Regions
7.9 Proteomics Technology Historic and Forecast Sales by Regions

8 . GLOBAL BLOOD CULTURE TEST MARKET ANALYSIS BY APPLICATION

8.1 Overview by Application
8.2 Historical and Forecast Data
8.3 Analysis by Application
8.4 Bacteremia Historic and Forecast Sales by Regions
8.5 Fungemia Historic and Forecast Sales by Regions
8.6 Mycobacterial Detection Historic and Forecast Sales by Regions

9 . GLOBAL BLOOD CULTURE TEST MARKET ANALYSIS BY END USER

9.1 Overview by End User
9.2 Historical and Forecast Data
9.3 Analysis by End User
9.4 Hospital Laboratories Historic and Forecast Sales by Regions
9.5 Reference Laboratories Historic and Forecast Sales by Regions
9.6 Academic Research Laboratories Historic and Forecast Sales by Regions
9.7 Other Laboratories Historic and Forecast Sales by Regions

10 . GLOBAL BLOOD CULTURE TEST MARKET ANALYSIS BY GEOGRAPHY

10.1. Regional Outlook
10.2. Introduction
10.3. North America Sales Analysis
- 10.3.1. Overview, Historic and Forecast Data Sales Analysis
- 10.3.2. North America By Segment Sales Analysis
- 10.3.3. North America By Country Sales Analysis
- 10.3.4. United State Sales Analysis
- 10.3.5. Canada Sales Analysis
- 10.3.6. Mexico Sales Analysis
10.4. Europe Sales Analysis
- 10.4.1. Overview, Historic and Forecast Data Sales Analysis
- 10.4.2. Europe by Segment Sales Analysis
- 10.4.3. Europe by Country Sales Analysis
- 10.4.4. United Kingdom Sales Analysis
- 10.4.5. France Sales Analysis
- 10.4.6. Germany Sales Analysis
- 10.4.7. Italy Sales Analysis
- 10.4.8. Russia Sales Analysis
- 10.4.9. Rest Of Europe Sales Analysis
10.5. Asia Pacific Sales Analysis
- 10.5.1. Overview, Historic and Forecast Data Sales Analysis
- 10.5.2. Asia Pacific by Segment Sales Analysis
- 10.5.3. Asia Pacific by Country Sales Analysis
- 10.5.4. China Sales Analysis
- 10.5.5. India Sales Analysis
- 10.5.6. Japan Sales Analysis
- 10.5.7. South Korea Sales Analysis
- 10.5.8. Australia Sales Analysis
- 10.5.9. South East Asia Sales Analysis
- 10.5.10. Rest Of Asia Pacific Sales Analysis
10.6. Latin America Sales Analysis
- 10.6.1. Overview, Historic and Forecast Data Sales Analysis
- 10.6.2. Latin America by Segment Sales Analysis
- 10.6.3. Latin America by Country Sales Analysis
- 10.6.4. Brazil Sales Analysis
- 10.6.5. Argentina Sales Analysis
- 10.6.6. Peru Sales Analysis
- 10.6.7. Chile Sales Analysis
- 10.6.8. Rest of Latin America Sales Analysis
10.7. Middle East & Africa Sales Analysis
- 10.7.1. Overview, Historic and Forecast Data Sales Analysis
- 10.7.2. Middle East & Africa by Segment Sales Analysis
- 10.7.3. Middle East & Africa by Country Sales Analysis
- 10.7.4. Saudi Arabia Sales Analysis
- 10.7.5. UAE Sales Analysis
- 10.7.6. Israel Sales Analysis
- 10.7.7. South Africa Sales Analysis
- 10.7.8. Rest Of Middle East And Africa Sales Analysis

11 . COMPETITIVE LANDSCAPE OF THE BLOOD CULTURE TEST COMPANIES

11.1. Blood Culture Test Market Competition
11.2. Partnership/Collaboration/Agreement
11.3. Merger And Acquisitions
11.4. New Product Launch
11.5. Other Developments

12 . COMPANY PROFILES OF BLOOD CULTURE TEST INDUSTRY

12.1. Company Share Analysis
12.2. Market Concentration Rate
12.3. Becton
- 12.3.1. Company Overview
- 12.3.2. Company Revenue
- 12.3.3. Products
- 12.3.4. Recent Developments
12.4. Dickinson and Company (US)
- 12.4.1. Company Overview
- 12.4.2. Company Revenue
- 12.4.3. Products
- 12.4.4. Recent Developments
12.5. bioMerieux SA (France)
- 12.5.1. Company Overview
- 12.5.2. Company Revenue
- 12.5.3. Products
- 12.5.4. Recent Developments
12.6. Thermo Fisher Scientific Inc. (US)
- 12.6.1. Company Overview
- 12.6.2. Company Revenue
- 12.6.3. Products
- 12.6.4. Recent Developments
12.7. Luminex Corporation (US)
- 12.7.1. Company Overview
- 12.7.2. Company Revenue
- 12.7.3. Products
- 12.7.4. Recent Developments
12.8. Danaher Corporation (US)
- 12.8.1. Company Overview
- 12.8.2. Company Revenue
- 12.8.3. Products
- 12.8.4. Recent Developments
12.9. Bruker Corporation (US)
- 12.9.1. Company Overview
- 12.9.2. Company Revenue
- 12.9.3. Products
- 12.9.4. Recent Developments
12.10. IRIDICA (a subsidiary of Abbott Laboratories) (US)
- 12.10.1. Company Overview
- 12.10.2. Company Revenue
- 12.10.3. Products
- 12.10.4. Recent Developments
12.11. Roche Diagnostics (Switzerland)
- 12.11.1. Company Overview
- 12.11.2. Company Revenue
- 12.11.3. Products
- 12.11.4. Recent Developments
12.12. T2 Biosystems Inc. (US)
- 12.12.1. Company Overview
- 12.12.2. Company Revenue
- 12.12.3. Products
- 12.12.4. Recent Developments
12.13. Anaerobe Systems Inc. (US)
- 12.13.1. Company Overview
- 12.13.2. Company Revenue
- 12.13.3. Products
- 12.13.4. Recent Developments
12.14. OpGen Inc. (US)
- 12.14.1. Company Overview
- 12.14.2. Company Revenue
- 12.14.3. Products
- 12.14.4. Recent Developments
12.15. Meditech Technologies India Private Limited (India)
- 12.15.1. Company Overview
- 12.15.2. Company Revenue
- 12.15.3. Products
- 12.15.4. Recent Developments
12.16. Carl Zeiss AG (Germany)
- 12.16.1. Company Overview
- 12.16.2. Company Revenue
- 12.16.3. Products
- 12.16.4. Recent Developments
12.17. Nikon Corporation (Japan)
- 12.17.1. Company Overview
- 12.17.2. Company Revenue
- 12.17.3. Products
- 12.17.4. Recent Developments
12.18. BINDER GmbH (Germany)
- 12.18.1. Company Overview
- 12.18.2. Company Revenue
- 12.18.3. Products
- 12.18.4. Recent Developments
12.19. Biobase Biotech (Jinan) Co. Ltd. (China)
- 12.19.1. Company Overview
- 12.19.2. Company Revenue
- 12.19.3. Products
- 12.19.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies